Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Prescription Opioid Dependence
NCT02543944Phase 3Completed
- Sponsor
- University of Arkansas
- Start
- Feb 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in opioid use disorder (OUD), sponsored by University of Arkansas. Started Feb 2016; status: completed.
02
Drugs
gabapentin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02543944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543944.